ResearchMoz

United Kingdom Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart Valves, Electrophysiology and Others

Publisher Name » GlobalData
Published Date » 2011-08-31
No. Of Pages » 370

GlobalDatas new report, United Kingdom Cardiovascular Devices Market Outlook to 2017 Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart Valves, Electrophysiology and Others provides key market data on the United Kingdom Cardiovascular Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within 10 market categories Cardiac Assist Devices, Cardiac Rhythm Management, Cardiovascular Monitoring and Diagnostic Devices, Cardiovascular Prosthetic Devices, Cardiovascular Surgery, Electrophysiology, External Defibrillators, Interventional Cardiology, Peripheral Vascular Devices and Prosthetic Heart Valves. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Scope
  • Market size and company share data for Cardiovascular Devices market categories Cardiac Assist Devices, Cardiac Rhythm Management, Cardiovascular Monitoring and Diagnostic Devices, Cardiovascular Prosthetic Devices, Cardiovascular Surgery, Electrophysiology, External Defibrillators, Interventional Cardiology, Peripheral Vascular Devices and Prosthetic Heart Valves.
  • Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within 10 market categories. Data from 2003 to 2010, forecast forward for 7 years to 2017. 
  • 2010 company shares and distribution shares data for each of the 10 market categories.
  • Global corporate-level profiles of key companies operating within the United Kingdom Cardiovascular Devicesmarket. 
  • Key players covered include Medtronic, Inc., Boston Scientific Corporation, St. Jude Medical, Inc., Abbott Laboratories, Cordis Corporation, Sorin S.p.A. and others.
Reasons to buy
  • Develop business strategies by identifying the key market categories and segments poised for strong growth.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the United Kingdom Cardiovascular Devices competitive landscape.
  • Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and whats the most preferred mode of product distribution Identify, understand and capitalize.
Table of Content

1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 What is This Report About?

3 Cardiovascular Devices In United Kingdom
3.1 Cardiovascular Devices, United Kingdom, Overall Revenue ($m), 2003-2017
3.2 Cardiovascular Devices Market, United Kingdom, Revenue Mix ($m), 2010
3.3 Cardiovascular Devices Market, United Kingdom, Category Contribution (%), 2010
3.4 Cardiovascular Devices, United Kingdom, Category Volume (Units), 2003-2017
3.5 Cardiovascular Devices, United Kingdom, Company Share (2009-2010)

4 Cardiac Assist Devices In United Kingdom
4.1 Cardiac Assist Devices, Market Segmentation
4.2 Cardiac Assist Devices Market, United Kingdom, Revenue Mix ($m), 2010
4.3 Cardiac Assist Devices Market, United Kingdom, Segment Contribution (%), 2010
4.4 Cardiac Assist Devices Overall Revenue (2003-2017)
4.4.1 Intra-Aortic Balloon Pumps Revenue (2003-2017)
4.4.2 Ventricular Assist Devices Revenue (2003-2017)
4.5 Cardiac Assist Devices Overall Volume (2003-2017)
4.5.1 Intra-Aortic Balloon Pumps Volume (2003-2017)
4.5.2 Ventricular Assist Devices Volume (2003-2017)
4.6 Cardiac Assist Devices Average Price (2003-2017)
4.7 Cardiac Assist Devices Distribution Share (2009-2010)
4.8 Cardiac Assist Devices, United Kingdom, Company Share (2009-2010)

5 Cardiac Rhythm Management In United Kingdom
5.1 Cardiac Rhythm Management, Market Segmentation
5.2 Cardiac Rhythm Management Market, United Kingdom, Revenue Mix ($m), 2010
5.3 Cardiac Rhythm Management Market, United Kingdom, Segment Contribution (%), 2010
5.4 Cardiac Rhythm Management Overall Revenue (2003-2017)
5.4.1 Cardiac Resynchronisation Therapy Revenue (2003-2017)
5.4.2 Implantable Cardioverter Defibrillators Revenue (2003-2017)
5.4.3 Pacemakers Revenue (2003-2017)
5.5 Cardiac Rhythm Management Overall Volume (2003-2017)
5.5.1 Cardiac Resynchronisation Therapy Volume (2003-2017)
5.5.2 Implantable Cardioverter Defibrillators Volume (2003-2017)
5.5.3 Pacemakers Volume (2003-2017)
5.6 Cardiac Rhythm Management Average Price (2003-2017)
5.7 Cardiac Rhythm Management Distribution Share (2009-2010)
5.8 Cardiac Rhythm Management, United Kingdom, Company Share (2009-2010)

6 Cardiovascular Monitoring and Diagnostic Devices In United Kingdom
6.1 Cardiovascular Monitoring and Diagnostic Devices, Market Segmentation
6.2 Cardiovascular Monitoring and Diagnostic Devices Market, United Kingdom, Revenue Mix ($m), 2010
6.3 Cardiovascular Monitoring and Diagnostic Devices Market, United Kingdom, Segment Contribution (%), 2010
6.4 Cardiovascular Monitoring and Diagnostic Devices Overall Revenue (2003-2017)
6.5 Cardiovascular Monitoring and Diagnostic Devices Overall Volume (2003-2017)
6.6 Cardiovascular Monitoring and Diagnostic Devices Average Price (2003-2017)
6.7 Cardiovascular Monitoring and Diagnostic Devices Distribution Share (2009-2010)
6.8 Cardiovascular Monitoring and Diagnostic Devices, United Kingdom, Company Share (2009-2010)

7 Cardiovascular Prosthetic Devices In United Kingdom
7.1 Cardiovascular Prosthetic Devices, Market Segmentation
7.2 Cardiovascular Prosthetic Devices Market, United Kingdom, Revenue Mix ($m), 2010
7.3 Cardiovascular Prosthetic Devices Market, United Kingdom, Segment Contribution (%), 2010
7.4 Cardiovascular Prosthetic Devices Overall Revenue (2003-2017)
7.4.1 Septal Occluders Revenue (2003-2017)
7.5 Cardiovascular Prosthetic Devices Overall Volume (2003-2017)
7.5.1 Septal Occluders Volume (2003-2017)
7.6 Cardiovascular Prosthetic Devices Average Price (2003-2017)
7.7 Cardiovascular Prosthetic Devices Distribution Share (2009-2010)
7.8 Cardiovascular Prosthetic Devices, United Kingdom, Company Share (2009-2010)

8 Cardiovascular Surgery In United Kingdom
8.1 Cardiovascular Surgery, Market Segmentation
8.2 Cardiovascular Surgery Market, United Kingdom, Revenue Mix ($m), 2010
8.3 Cardiovascular Surgery Market, United Kingdom, Segment Contribution (%), 2010
8.4 Cardiovascular Surgery Overall Revenue (2003-2017)
8.4.1 Beating Heart Surgery Systems Revenue (2003-2017)
8.4.2 Perfusion Disposables Revenue (2003-2017)
8.5 Cardiovascular Surgery Overall Volume (2003-2017)
8.5.1 Beating Heart Surgery Systems Volume (2003-2017)
8.5.2 Perfusion Disposables Volume (2003-2017)
8.6 Cardiovascular Surgery Average Price (2003-2017)
8.7 Cardiovascular Surgery Distribution Share (2009-2010)
8.8 Cardiovascular Surgery, United Kingdom, Company Share (2009-2010)

9 Electrophysiology In United Kingdom
9.1 Electrophysiology, Market Segmentation
9.2 Electrophysiology Market, United Kingdom, Revenue Mix ($m), 2010
9.3 Electrophysiology Market, United Kingdom, Segment Contribution (%), 2010
9.4 Electrophysiology Overall Revenue (2003-2017)
9.5 Electrophysiology Overall Volume (2003-2017)
9.6 Electrophysiology Average Price (2003-2017)
9.7 Electrophysiology Distribution Share (2009-2010)
9.8 Electrophysiology, United Kingdom, Company Share (2009-2010)

10 External Defibrillators In United Kingdom
10.1 External Defibrillators, Market Segmentation
10.2 External Defibrillators Market, United Kingdom, Revenue Mix ($m), 2010
10.3 External Defibrillators Market, United Kingdom, Segment Contribution (%), 2010
10.4 External Defibrillators Overall Revenue (2003-2017)
10.5 External Defibrillators Overall Volume (2003-2017)
10.6 External Defibrillators Average Price (2003-2017)
10.7 External Defibrillators Distribution Share (2009-2010)
10.8 External Defibrillators, United Kingdom, Company Share (2009-2010)

11 Interventional Cardiology In United Kingdom
11.1 Interventional Cardiology, Market Segmentation
11.2 Interventional Cardiology Market, United Kingdom, Revenue Mix ($m), 2010
11.3 Interventional Cardiology Market, United Kingdom, Segment Contribution (%), 2010
11.4 Interventional Cardiology Overall Revenue (2003-2017)
11.4.1 Cardiac Catheters Revenue (2003-2017)
11.4.2 Coronary Stents Revenue (2003-2017)
11.4.3 PTCA Balloons Revenue (2003-2017)
11.4.4 Intravascular Ultrasound Systems (IVUS) Revenue (2003-2017)
11.5 Interventional Cardiology Overall Volume (2003-2017)
11.5.1 Cardiac Catheters Volume (2003-2017)
11.5.2 Coronary Stents Volume (2003-2017)
11.5.3 PTCA Balloons Volume (2003-2017)
11.5.4 Intravascular Ultrasound Systems (IVUS) Volume (2003-2017)
11.6 Interventional Cardiology Average Price (2003-2017)
11.7 Interventional Cardiology Distribution Share (2009-2010)
11.8 Interventional Cardiology, United Kingdom, Company Share (2009-2010)
11.8.1 Cardiac Catheters, United Kingdom, Company Share (2009-2010)
11.8.2 Coronary Stents, United Kingdom, Company Share (2009-2010)

12 Peripheral Vascular Devices In United Kingdom
12.1 Peripheral Vascular Devices, Market Segmentation
12.2 Peripheral Vascular Devices Market, United Kingdom, Revenue Mix ($m), 2010
12.3 Peripheral Vascular Devices Market, United Kingdom, Segment Contribution (%), 2010
12.4 Peripheral Vascular Devices Overall Revenue (2003-2017)
12.4.1 Stent Grafts Revenue (2003-2017)
12.4.2 Inferior Vena Cava Filters (IVCF) Revenue (2003-2017)
12.4.3 Peripheral Vascular Stents Revenue (2003-2017)
12.5 Peripheral Vascular Devices Overall Volume (2003-2017)
12.5.1 Stent Grafts Volume (2003-2017)
12.5.2 Inferior Vena Cava Filters (IVCF) Volume (2003-2017)
12.5.3 Peripheral Vascular Stents Volume (2003-2017)
12.6 Peripheral Vascular Devices Average Price (2003-2017)
12.7 Peripheral Vascular Devices Distribution Share (2009-2010)
12.8 Peripheral Vascular Devices, United Kingdom, Company Share (2009-2010)

13 Prosthetic Heart Valves In United Kingdom
13.1 Prosthetic Heart Valves, Market Segmentation
13.2 Prosthetic Heart Valves Market, United Kingdom, Revenue Mix ($m), 2010
13.3 Prosthetic Heart Valves Market, United Kingdom, Segment Contribution (%), 2010
13.4 Prosthetic Heart Valves Overall Revenue (2003-2017)
13.4.1 Mechanical Heart Valves Revenue (2003-2017)
13.4.2 Tissue Heart Valves Revenue (2003-2017)
13.5 Prosthetic Heart Valves Overall Volume (2003-2017)
13.5.1 Mechanical Heart Valves Volume (2003-2017)
13.5.2 Tissue Heart Valves Volume (2003-2017)
13.6 Prosthetic Heart Valves Average Price (2003-2017)
13.7 Prosthetic Heart Valves Distribution Share (2009-2010)
13.8 Prosthetic Heart Valves, United Kingdom, Company Share (2009-2010)

14 Overview of Key Companies in United Kingdom Cardiovascular Devices Market
14.1 Medtronic, Inc.
14.1.1 Company Overview
14.1.2 Share in the United Kingdom Cardiovascular Devices Market
14.2 Boston Scientific Corporation
14.2.1 Company Overview
14.2.2 Share in the United Kingdom Cardiovascular Devices Market
14.3 St. Jude Medical, Inc.
14.3.1 Company Overview
14.3.2 Share in the United Kingdom Cardiovascular Devices Market
14.4 Abbott Laboratories
14.4.1 Company Overview
14.4.2 Share in the United Kingdom Cardiovascular Devices Market
14.5 Cordis Corporation
14.5.1 Company Overview
14.5.2 Share in the United Kingdom Cardiovascular Devices Market
14.6 Sorin S.p.A.
14.6.1 Company Overview
14.6.2 Share in the United Kingdom Cardiovascular Devices Market
14.7 Edwards Lifesciences Corporation
14.7.1 Company Overview
14.8 BIOTRONIK SE & Co. KG
14.8.1 Company Overview
14.9 Terumo Corporation
14.9.1 Company Overview
14.10 MAQUET GmbH & Co. KG
14.10.1 Company Overview
14.11 Philips Healthcare
14.11.1 Company Overview
14.12 Biosense Webster, Inc.
14.12.1 Company Overview
14.13 C. R. Bard, Inc.
14.13.1 Company Overview
14.14 Thoratec Corporation
14.14.1 Company Overview
14.15 GE Healthcare
14.15.1 Company Overview
14.16 ASAHI INTECC CO., LTD.
14.16.1 Company Overview
14.17 Volcano Corporation
14.17.1 Company Overview
14.18 HeartWare International, Inc.
14.18.1 Company Overview
14.19 Goodman Co., Ltd.
14.19.1 Company Overview
14.20 Berlin Heart GmbH
14.20.1 Company Overview
14.21 Vascular Concepts Limited
14.21.1 Company Overview
14.22 Teleflex Incorporated
14.22.1 Company Overview
14.23 AGA Medical Holdings, Inc.
14.23.1 Company Overview
14.24 ZOLL Medical Corporation
14.24.1 Company Overview
14.25 Welch Allyn Inc.
14.25.1 Company Overview
14.26 Covidien plc
14.26.1 Company Overview
14.27 Schiller AG
14.27.1 Company Overview
14.28 Cardiac Science Corporation
14.28.1 Company Overview
14.29 Mortara Instrument, Inc.
14.29.1 Company Overview
14.30 ev3 Inc.
14.30.1 Company Overview
14.31 W. L. Gore & Associates, Inc.
14.31.1 Company Overview
14.32 OSI Systems, Inc.
14.32.1 Company Overview
14.33 Fukuda Denshi Co., Ltd.
14.33.1 Company Overview

15 Cardiovascular Devices Market Pipeline Products
15.1 Cardiac Assist Devices Market Pipeline Products
15.2 Cardiac Rhythm Management Market Pipeline Products
15.3 Cardiovascular Monitoring and Diagnostic Devices Market Pipeline Products
15.4 Cardiovascular Prosthetic Devices Market Pipeline Products
15.5 Cardiovascular Surgery Market Pipeline Products
15.6 Electrophysiology Market Pipeline Products
15.7 Interventional Cardiology Market Pipeline Products
15.8 Peripheral Vascular Devices Market Pipeline Products
15.9 Prosthetic Heart Valves Market Pipeline Products

16 Financial Deals Landscape
16.1 Partnerships
16.1.1 LiDCO Enters Into Distribution Agreement with ICU Medical
16.1.2 LiDCO Signs Licensing Agreement With ICU Medical
16.1.3 Endosense Enters Into Partnership With GE Healthcare
16.1.4 AccessClosure Enters Into Distribution Agreement With Biosensors International
16.1.5 LiDCO Enters Into Co-Marketing Agreement With Argon Medical
16.1.6 Hansen Medical Signs An Agreement With St. Jude Medical

17 Recent Developments
17.1 Strategy and Business Planning
17.1.1 Nov 30, 2010: Hansen Opens European Commercialization And Training Center
17.2 Legal and Regulatory
17.2.1 Jun 16, 2011: St. Jude's AGA Medical Subsidiary Files Patent Infringement Lawsuits Against Occlutech
17.3 Government and Public Interest
17.3.1 Sep 21, 2010: Study Shows MRI May Be Sufficient For Routine Surveillance Of Great Vessel Stents
17.3.2 Aug 30, 2010: Trial Of Single And Bilateral Mammary Artery Grafts Is ‘Testament’ To Safety Of Each Procedure: ESC

18 Appendix
18.1 Definitions of Markets Covered in the Report
18.1.1 Cardiovascular Devices
18.2 Secondary Research
18.3 Primary Research
18.4 Models
18.5 Forecasts
18.6 Expert Panels
18.7 GlobalData Consulting
18.8 Currency Conversion
18.9 Contact Us
18.10 Disclaimer

List of Tables


Table 1: Cardiovascular Devices, United Kingdom, Overall Revenue ($m), 2003-2017 25
Table 2: Cardiovascular Devices Market, United Kingdom, Category Contribution (%), 2010 27
Table 3: Cardiovascular Devices, United Kingdom, Cross-Category Analysis, 2003-2017 29
Table 4: Cardiovascular Devices, United Kingdom, Overall Revenue ($m), Historic, 2003-2010 31
Table 5: Cardiovascular Devices, United Kingdom, Overall Revenue ($m), Forecast, 2010-2017 33
Table 6: Cardiovascular Devices, United Kingdom, Category Volume (Units), 2003-2017 35
Table 7: Cardiovascular Devices, United Kingdom, Category Volume (Units), Historic, 2003-2010 37
Table 8: Cardiovascular Devices, United Kingdom, Category Volume (Units), Forecast, 2010-2017 39
Table 9: Cardiovascular Devices, United Kingdom, Company Share by Revenue ($m), 2009-2010 41
Table 10: Cardiac Assist Devices Market, United Kingdom, Segment Contribution (%), 2010 44
Table 11: Cardiac Assist Devices, United Kingdom, Revenue ($m) by Segment, Historic, 2003-2010 46
Table 12: Cardiac Assist Devices, United Kingdom, Revenue ($m) by Segment, Forecast, 2010-2017 48
Table 13: Intra-Aortic Balloon Pumps, United Kingdom, Revenue ($m) by Sub-Segment, Historic, 2003-2010 50
Table 14: Intra-Aortic Balloon Pumps, United Kingdom, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 52
Table 15: Ventricular Assist Devices, United Kingdom, Revenue ($m) by Sub-Segment, Historic, 2003-2010 54
Table 16: Ventricular Assist Devices, United Kingdom, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 56
Table 17: Cardiac Assist Devices, United Kingdom, Volume (Units) by Segment, Historic, 2003-2010 57
Table 18: Cardiac Assist Devices, United Kingdom, Volume (Units) by Segment, Forecast, 2010-2017 58
Table 19: Intra-Aortic Balloon Pumps, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2003-2010 59
Table 20: Intra-Aortic Balloon Pumps, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2010-2017 60
Table 21: Ventricular Assist Devices, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2003-2010 62
Table 22: Ventricular Assist Devices, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2010-2017 64
Table 23: Cardiac Assist Devices, United Kingdom, Average Price ($), Historic, 2003-2010 65
Table 24: Cardiac Assist Devices, United Kingdom, Average Price ($), Forecast, 2010-2017 66
Table 25: Cardiac Assist Devices, United Kingdom, Distribution Share by Revenue ($m), 2009-2010 67
Table 26: Cardiac Assist Devices, United Kingdom, Company Share by Revenue ($m), 2009-2010 69
Table 27: Cardiac Rhythm Management Market, United Kingdom, Segment Contribution (%), 2010 72
Table 28: Cardiac Rhythm Management, United Kingdom, Revenue ($m) by Segment, Historic, 2003-2010 74
Table 29: Cardiac Rhythm Management, United Kingdom, Revenue ($m) by Segment, Forecast, 2010-2017 76
Table 30: Cardiac Resynchronisation Therapy, United Kingdom, Revenue ($m) by Sub-Segment, Historic, 2003-2010 78
Table 31: Cardiac Resynchronisation Therapy, United Kingdom, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 80
Table 32: Implantable Cardioverter Defibrillators, United Kingdom, Revenue ($m) by Sub-Segment, Historic, 2003-2010 82
Table 33: Implantable Cardioverter Defibrillators, United Kingdom, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 84
Table 34: Pacemakers, United Kingdom, Revenue ($m) by Sub-Segment, Historic, 2003-2010 86
Table 35: Pacemakers, United Kingdom, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 88
Table 36: Cardiac Rhythm Management, United Kingdom, Volume (Units) by Segment, Historic, 2003-2010 90
Table 37: Cardiac Rhythm Management, United Kingdom, Volume (Units) by Segment, Forecast, 2010-2017 92
Table 38: Cardiac Resynchronisation Therapy, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2003-2010 94
Table 39: Cardiac Resynchronisation Therapy, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2010-2017 96
Table 40: Implantable Cardioverter Defibrillators, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2003-2010 98
Table 41: Implantable Cardioverter Defibrillators, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2010-2017 100
Table 42: Pacemakers, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2003-2010 102
Table 43: Pacemakers, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2010-2017 104
Table 44: Cardiac Rhythm Management, United Kingdom, Average Price ($), Historic, 2003-2010 105
Table 45: Cardiac Rhythm Management, United Kingdom, Average Price ($), Forecast, 2010-2017 105
Table 46: Cardiac Rhythm Management, United Kingdom, Distribution Share by Revenue ($m), 2009-2010 106
Table 47: Cardiac Rhythm Management, United Kingdom, Company Share by Revenue ($m), 2009-2010 108
Table 48: Cardiovascular Monitoring and Diagnostic Devices Market, United Kingdom, Segment Contribution (%), 2010 111
Table 49: Cardiovascular Monitoring and Diagnostic Devices, United Kingdom, Revenue ($m) by Segment, Historic, 2003-2010 113
Table 50: Cardiovascular Monitoring and Diagnostic Devices, United Kingdom, Revenue ($m) by Segment, Forecast, 2010-2017 115
Table 51: Cardiovascular Monitoring and Diagnostic Devices, United Kingdom, Volume (Units) by Segment, Historic, 2003-2010 117
Table 52: Cardiovascular Monitoring and Diagnostic Devices, United Kingdom, Volume (Units) by Segment, Forecast, 2010-2017 119
Table 53: Cardiovascular Monitoring and Diagnostic Devices, United Kingdom, Average Price ($), Historic, 2003-2010 120
Table 54: Cardiovascular Monitoring and Diagnostic Devices, United Kingdom, Average Price ($), Forecast, 2010-2017 121
Table 55: Cardiovascular Monitoring and Diagnostic Devices, United Kingdom, Distribution Share by Revenue ($m), 2009-2010 122
Table 56: Cardiovascular Monitoring and Diagnostic Devices, United Kingdom, Company Share by Revenue ($m), 2009-2010 124
Table 57: Cardiovascular Prosthetic Devices Market, United Kingdom, Segment Contribution (%), 2010 127
Table 58: Cardiovascular Prosthetic Devices, United Kingdom, Revenue ($m) by Segment, Historic, 2003-2010 129
Table 59: Cardiovascular Prosthetic Devices, United Kingdom, Revenue ($m) by Segment, Forecast, 2010-2017 131
Table 60: Septal Occluders, United Kingdom, Revenue ($m) by Sub-Segment, Historic, 2003-2010 133
Table 61: Septal Occluders, United Kingdom, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 135
Table 62: Cardiovascular Prosthetic Devices, United Kingdom, Volume (Units) by Segment, Historic, 2003-2010 137
Table 63: Cardiovascular Prosthetic Devices, United Kingdom, Volume (Units) by Segment, Forecast, 2010-2017 139
Table 64: Septal Occluders, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2003-2010 141
Table 65: Septal Occluders, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2010-2017 143
Table 66: Cardiovascular Prosthetic Devices, United Kingdom, Average Price ($), Historic, 2003-2010 144
Table 67: Cardiovascular Prosthetic Devices, United Kingdom, Average Price ($), Forecast, 2010-2017 144
Table 68: Cardiovascular Prosthetic Devices, United Kingdom, Distribution Share by Revenue ($m), 2009-2010 145
Table 69: Cardiovascular Prosthetic Devices, United Kingdom, Company Share by Revenue ($m), 2009-2010 147
Table 70: Cardiovascular Surgery Market, United Kingdom, Segment Contribution (%), 2010 150
Table 71: Cardiovascular Surgery, United Kingdom, Revenue ($m) by Segment, Historic, 2003-2010 152
Table 72: Cardiovascular Surgery, United Kingdom, Revenue ($m) by Segment, Forecast, 2010-2017 154
Table 73: Beating Heart Surgery Systems, United Kingdom, Revenue ($m) by Sub-Segment, Historic, 2003-2010 156
Table 74: Beating Heart Surgery Systems, United Kingdom, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 158
Table 75: Perfusion Disposables, United Kingdom, Revenue ($m) by Sub-Segment, Historic, 2003-2010 160
Table 76: Perfusion Disposables, United Kingdom, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 162
Table 77: Cardiovascular Surgery, United Kingdom, Volume (Units) by Segment, Historic, 2003-2010 164
Table 78: Cardiovascular Surgery, United Kingdom, Volume (Units) by Segment, Forecast, 2010-2017 166
Table 79: Beating Heart Surgery Systems, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2003-2010 168
Table 80: Beating Heart Surgery Systems, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2010-2017 170
Table 81: Perfusion Disposables, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2003-2010 171
Table 82: Perfusion Disposables, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2010-2017 173
Table 83: Cardiovascular Surgery, United Kingdom, Average Price ($), Historic, 2003-2010 174
Table 84: Cardiovascular Surgery, United Kingdom, Average Price ($), Forecast, 2010-2017 174
Table 85: Cardiovascular Surgery, United Kingdom, Distribution Share by Revenue ($m), 2009-2010 175
Table 86: Cardiovascular Surgery, United Kingdom, Company Share by Revenue ($m), 2009-2010 176
Table 87: Electrophysiology Market, United Kingdom, Segment Contribution (%), 2010 179
Table 88: Electrophysiology, United Kingdom, Revenue ($m) by Segment, Historic, 2003-2010 181
Table 89: Electrophysiology, United Kingdom, Revenue ($m) by Segment, Forecast, 2010-2017 183
Table 90: Electrophysiology, United Kingdom, Volume (Units) by Segment, Historic, 2003-2010 185
Table 91: Electrophysiology, United Kingdom, Volume (Units) by Segment, Forecast, 2010-2017 187
Table 92: Electrophysiology, United Kingdom, Average Price ($), Historic, 2003-2010 188
Table 93: Electrophysiology, United Kingdom, Average Price ($), Forecast, 2010-2017 188
Table 94: Electrophysiology, United Kingdom, Distribution Share by Revenue ($m), 2009-2010 189
Table 95: Electrophysiology, United Kingdom, Company Share by Revenue ($m), 2009-2010 191
Table 96: External Defibrillators Market, United Kingdom, Segment Contribution (%), 2010 194
Table 97: External Defibrillators, United Kingdom, Revenue ($m) by Segment, Historic, 2003-2010 196
Table 98: External Defibrillators, United Kingdom, Revenue ($m) by Segment, Forecast, 2010-2017 198
Table 99: External Defibrillators, United Kingdom, Volume (Units) by Segment, Historic, 2003-2010 200
Table 100: External Defibrillators, United Kingdom, Volume (Units) by Segment, Forecast, 2010-2017 202
Table 101: External Defibrillators, United Kingdom, Average Price ($), Historic, 2003-2010 203
Table 102: External Defibrillators, United Kingdom, Average Price ($), Forecast, 2010-2017 203
Table 103: External Defibrillators, United Kingdom, Distribution Share by Revenue ($m), 2009-2010 204
Table 104: External Defibrillators, United Kingdom, Company Share by Revenue ($m), 2009-2010 206
Table 105: Interventional Cardiology Market, United Kingdom, Segment Contribution (%), 2010 209
Table 106: Interventional Cardiology, United Kingdom, Revenue ($m) by Segment, Historic, 2003-2010 211
Table 107: Interventional Cardiology, United Kingdom, Revenue ($m) by Segment, Forecast, 2010-2017 213
Table 108: Cardiac Catheters, United Kingdom, Revenue ($m) by Sub-Segment, Historic, 2003-2010 215
Table 109: Cardiac Catheters, United Kingdom, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 217
Table 110: Coronary Stents, United Kingdom, Revenue ($m) by Sub-Segment, Historic, 2003-2010 219
Table 111: Coronary Stents, United Kingdom, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 221
Table 112: PTCA Balloons, United Kingdom, Revenue ($m) by Sub-Segment, Historic, 2003-2010 223
Table 113: PTCA Balloons, United Kingdom, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 225
Table 114: Intravascular Ultrasound Systems (IVUS), United Kingdom, Revenue ($m) by Sub-Segment, Historic, 2003-2010 227
Table 115: Intravascular Ultrasound Systems (IVUS), United Kingdom, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 229
Table 116: Interventional Cardiology, United Kingdom, Volume (Units) by Segment, Historic, 2003-2010 231
Table 117: Interventional Cardiology, United Kingdom, Volume (Units) by Segment, Forecast, 2010-2017 233
Table 118: Cardiac Catheters, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2003-2010 234
Table 119: Cardiac Catheters, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2010-2017 235
Table 120: Coronary Stents, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2003-2010 236
Table 121: Coronary Stents, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2010-2017 237
Table 122: PTCA Balloons, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2003-2010 239
Table 123: PTCA Balloons, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2010-2017 241
Table 124: Intravascular Ultrasound Systems (IVUS), United Kingdom, Volume (Units) by Sub-Segment, Historic, 2003-2010 243
Table 125: Intravascular Ultrasound Systems (IVUS), United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2010-2017 245
Table 126: Interventional Cardiology, United Kingdom, Average Price ($), Historic, 2003-2010 246
Table 127: Interventional Cardiology, United Kingdom, Average Price ($), Forecast, 2010-2017 247
Table 128: Interventional Cardiology, United Kingdom, Distribution Share by Revenue ($m), 2009-2010 248
Table 129: Interventional Cardiology, United Kingdom, Company Share by Revenue ($m), 2009-2010 250
Table 130: Cardiac Catheters, United Kingdom, Company Share by Revenue ($m), 2009-2010 252
Table 131: Coronary Stents, United Kingdom, Company Share by Revenue ($m), 2009-2010 253
Table 132: Peripheral Vascular Devices Market, United Kingdom, Segment Contribution (%), 2010 257
Table 133: Peripheral Vascular Devices, United Kingdom, Revenue ($m) by Segment, Historic, 2003-2010 259
Table 134: Peripheral Vascular Devices, United Kingdom, Revenue ($m) by Segment, Forecast, 2010-2017 261
Table 135: Stent Grafts, United Kingdom, Revenue ($m) by Sub-Segment, Historic, 2003-2010 263
Table 136: Stent Grafts, United Kingdom, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 265
Table 137: Inferior Vena Cava Filters (IVCF), United Kingdom, Revenue ($m) by Sub-Segment, Historic, 2003-2010 266
Table 138: Inferior Vena Cava Filters (IVCF), United Kingdom, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 267
Table 139: Peripheral Vascular Stents, United Kingdom, Revenue ($m) by Sub-Segment, Historic, 2003-2010 269
Table 140: Peripheral Vascular Stents, United Kingdom, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 271
Table 141: Peripheral Vascular Devices, United Kingdom, Volume (Units) by Segment, Historic, 2003-2010 273
Table 142: Peripheral Vascular Devices, United Kingdom, Volume (Units) by Segment, Forecast, 2010-2017 275
Table 143: Stent Grafts, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2003-2010 277
Table 144: Stent Grafts, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2010-2017 278
Table 145: Inferior Vena Cava Filters (IVCF), United Kingdom, Volume (Units) by Sub-Segment, Historic, 2003-2010 280
Table 146: Inferior Vena Cava Filters (IVCF), United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2010-2017 282
Table 147: Peripheral Vascular Stents, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2003-2010 284
Table 148: Peripheral Vascular Stents, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2010-2017 286
Table 149: Peripheral Vascular Devices, United Kingdom, Average Price ($), Historic, 2003-2010 287
Table 150: Peripheral Vascular Devices, United Kingdom, Average Price ($), Forecast, 2010-2017 288
Table 151: Peripheral Vascular Devices, United Kingdom, Distribution Share by Revenue ($m), 2009-2010 289
Table 152: Peripheral Vascular Devices, United Kingdom, Company Share by Revenue ($m), 2009-2010 291
Table 153: Prosthetic Heart Valves Market, United Kingdom, Segment Contribution (%), 2010 294
Table 154: Prosthetic Heart Valves, United Kingdom, Revenue ($m) by Segment, Historic, 2003-2010 296
Table 155: Prosthetic Heart Valves, United Kingdom, Revenue ($m) by Segment, Forecast, 2010-2017 298
Table 156: Mechanical Heart Valves, United Kingdom, Revenue ($m) by Sub-Segment, Historic, 2003-2010 300
Table 157: Mechanical Heart Valves, United Kingdom, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 302
Table 158: Tissue Heart Valves, United Kingdom, Revenue ($m) by Sub-Segment, Historic, 2003-2010 304
Table 159: Tissue Heart Valves, United Kingdom, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 306
Table 160: Prosthetic Heart Valves, United Kingdom, Volume (Units) by Segment, Historic, 2003-2010 308
Table 161: Prosthetic Heart Valves, United Kingdom, Volume (Units) by Segment, Forecast, 2010-2017 310
Table 162: Mechanical Heart Valves, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2003-2010 312
Table 163: Mechanical Heart Valves, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2010-2017 314
Table 164: Tissue Heart Valves, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2003-2010 316
Table 165: Tissue Heart Valves, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2010-2017 318
Table 166: Prosthetic Heart Valves, United Kingdom, Average Price ($), Historic, 2003-2010 319
Table 167: Prosthetic Heart Valves, United Kingdom, Average Price ($), Forecast, 2010-2017 319
Table 168: Prosthetic Heart Valves, United Kingdom, Distribution Share by Revenue ($m), 2009-2010 320
Table 169: Prosthetic Heart Valves, United Kingdom, Company Share by Revenue ($m), 2009-2010 321
Table 170: Cardiac Assist Devices Market Pipeline Products 337
Table 171: Cardiac Rhythm Management Market Pipeline Products 338
Table 172: Cardiovascular Monitoring and Diagnostic Devices Market Pipeline Products 339
Table 173: Cardiovascular Prosthetic Devices Market Pipeline Products 340
Table 174: Cardiovascular Surgery Market Pipeline Products 341
Table 175: Electrophysiology Market Pipeline Products 342
Table 176: Interventional Cardiology Market Pipeline Products 343
Table 177: Peripheral Vascular Devices Market Pipeline Products 345
Table 178: Prosthetic Heart Valves Market Pipeline Products 347
Table 179: LiDCO Enters Into Distribution Agreement With ICU Medical 348
Table 180: LiDCO Signs Licensing Agreement With ICU Medical 349
Table 181: Endosense Enters Into Partnership With GE Healthcare 350
Table 182: AccessClosure Enters Into Distribution Agreement With Biosensors International 351
Table 183: LiDCO Enters Into Co-Marketing Agreement With Argon Medical 352
Table 184: Hansen Medical Signs An Agreement With St. Jude Medical 353
Table 185: USD to Local Currency, United Kingdom, Average Actual Rate 2003-2010 370

List of Figures


Figure 1: Cardiovascular Devices, United Kingdom, Overall Revenue ($m), 2003-2017 24
Figure 2: Cardiovascular Devices Market, United Kingdom, Revenue Mix ($m), 2010 26
Figure 3: Cardiovascular Devices Market, United Kingdom, Category Contribution (%), 2010 27
Figure 4: Cardiovascular Devices, United Kingdom, Cross-Category Analysis, 2003-2017 28
Figure 5: Cardiovascular Devices, United Kingdom, Overall Revenue ($m), Historic, 2003-2010 30
Figure 6: Cardiovascular Devices, United Kingdom, Overall Revenue ($m), Forecast, 2010-2017 32
Figure 7: Cardiovascular Devices, United Kingdom, Category Volume (Units), 2003-2017 34
Figure 8: Cardiovascular Devices, United Kingdom, Category Volume (Units), Historic, 2003-2010 36
Figure 9: Cardiovascular Devices, United Kingdom, Category Volume (Units), Forecast, 2010-2017 38
Figure 10: Cardiovascular Devices, United Kingdom, Company Share (%), 2010 40
Figure 11: Cardiac Assist Devices, Market Segmentation 42
Figure 12: Cardiac Assist Devices Market, United Kingdom, Revenue Mix ($m), 2010 43
Figure 13: Cardiac Assist Devices Market, United Kingdom, Segment Contribution (%), 2010 44
Figure 14: Cardiac Assist Devices, United Kingdom, Revenue ($m) by Segment, Historic, 2003-2010 45
Figure 15: Cardiac Assist Devices, United Kingdom, Revenue ($m) by Segment, Forecast, 2010-2017 47
Figure 16: Intra-Aortic Balloon Pumps, United Kingdom, Revenue ($m) by Sub-Segment, Historic, 2003-2010 49
Figure 17: Intra-Aortic Balloon Pumps, United Kingdom, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 51
Figure 18: Ventricular Assist Devices, United Kingdom, Revenue ($m) by Sub-Segment, Historic, 2003-2010 53
Figure 19: Ventricular Assist Devices, United Kingdom, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 55
Figure 20: Cardiac Assist Devices, United Kingdom, Volume (Units) by Segment, Historic, 2003-2010 57
Figure 21: Cardiac Assist Devices, United Kingdom, Volume (Units) by Segment, Forecast, 2010-2017 58
Figure 22: Intra-Aortic Balloon Pumps, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2003-2010 59
Figure 23: Intra-Aortic Balloon Pumps, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2010-2017 60
Figure 24: Ventricular Assist Devices, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2003-2010 61
Figure 25: Ventricular Assist Devices, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2010-2017 63
Figure 26: Cardiac Assist Devices, United Kingdom, Company Share (%), 2010 68
Figure 27: Cardiac Rhythm Management, Market Segmentation 70
Figure 28: Cardiac Rhythm Management Market, United Kingdom, Revenue Mix ($m), 2010 71
Figure 29: Cardiac Rhythm Management Market, United Kingdom, Segment Contribution (%), 2010 72
Figure 30: Cardiac Rhythm Management, United Kingdom, Revenue ($m) by Segment, Historic, 2003-2010 73
Figure 31: Cardiac Rhythm Management, United Kingdom, Revenue ($m) by Segment, Forecast, 2010-2017 75
Figure 32: Cardiac Resynchronisation Therapy, United Kingdom, Revenue ($m) by Sub-Segment, Historic, 2003-2010 77
Figure 33: Cardiac Resynchronisation Therapy, United Kingdom, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 79
Figure 34: Implantable Cardioverter Defibrillators, United Kingdom, Revenue ($m) by Sub-Segment, Historic, 2003-2010 81
Figure 35: Implantable Cardioverter Defibrillators, United Kingdom, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 83
Figure 36: Pacemakers, United Kingdom, Revenue ($m) by Sub-Segment, Historic, 2003-2010 85
Figure 37: Pacemakers, United Kingdom, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 87
Figure 38: Cardiac Rhythm Management, United Kingdom, Volume (Units) by Segment, Historic, 2003-2010 89
Figure 39: Cardiac Rhythm Management, United Kingdom, Volume (Units) by Segment, Forecast, 2010-2017 91
Figure 40: Cardiac Resynchronisation Therapy, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2003-2010 93
Figure 41: Cardiac Resynchronisation Therapy, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2010-2017 95
Figure 42: Implantable Cardioverter Defibrillators, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2003-2010 97
Figure 43: Implantable Cardioverter Defibrillators, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2010-2017 99
Figure 44: Pacemakers, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2003-2010 101
Figure 45: Pacemakers, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2010-2017 103
Figure 46: Cardiac Rhythm Management, United Kingdom, Company Share (%), 2010 107
Figure 47: Cardiovascular Monitoring and Diagnostic Devices, Market Segmentation 109
Figure 48: Cardiovascular Monitoring and Diagnostic Devices Market, United Kingdom, Revenue Mix ($m), 2010 110
Figure 49: Cardiovascular Monitoring and Diagnostic Devices Market, United Kingdom, Segment Contribution (%), 2010 111
Figure 50: Cardiovascular Monitoring and Diagnostic Devices, United Kingdom, Revenue ($m) by Segment, Historic, 2003-2010 112
Figure 51: Cardiovascular Monitoring and Diagnostic Devices, United Kingdom, Revenue ($m) by Segment, Forecast, 2010-2017 114
Figure 52: Cardiovascular Monitoring and Diagnostic Devices, United Kingdom, Volume (Units) by Segment, Historic, 2003-2010 116
Figure 53: Cardiovascular Monitoring and Diagnostic Devices, United Kingdom, Volume (Units) by Segment, Forecast, 2010-2017 118
Figure 54: Cardiovascular Monitoring and Diagnostic Devices, United Kingdom, Company Share (%), 2010 123
Figure 55: Cardiovascular Prosthetic Devices, Market Segmentation 125
Figure 56: Cardiovascular Prosthetic Devices Market, United Kingdom, Revenue Mix ($m), 2010 126
Figure 57: Cardiovascular Prosthetic Devices Market, United Kingdom, Segment Contribution (%), 2010 127
Figure 58: Cardiovascular Prosthetic Devices, United Kingdom, Revenue ($m) by Segment, Historic, 2003-2010 128
Figure 59: Cardiovascular Prosthetic Devices, United Kingdom, Revenue ($m) by Segment, Forecast, 2010-2017 130
Figure 60: Septal Occluders, United Kingdom, Revenue ($m) by Sub-Segment, Historic, 2003-2010 132
Figure 61: Septal Occluders, United Kingdom, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 134
Figure 62: Cardiovascular Prosthetic Devices, United Kingdom, Volume (Units) by Segment, Historic, 2003-2010 136
Figure 63: Cardiovascular Prosthetic Devices, United Kingdom, Volume (Units) by Segment, Forecast, 2010-2017 138
Figure 64: Septal Occluders, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2003-2010 140
Figure 65: Septal Occluders, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2010-2017 142
Figure 66: Cardiovascular Prosthetic Devices, United Kingdom, Company Share (%), 2010 146
Figure 67: Cardiovascular Surgery, Market Segmentation 148
Figure 68: Cardiovascular Surgery Market, United Kingdom, Revenue Mix ($m), 2010 149
Figure 69: Cardiovascular Surgery Market, United Kingdom, Segment Contribution (%), 2010 150
Figure 70: Cardiovascular Surgery, United Kingdom, Revenue ($m) by Segment, Historic, 2003-2010 151
Figure 71: Cardiovascular Surgery, United Kingdom, Revenue ($m) by Segment, Forecast, 2010-2017 153
Figure 72: Beating Heart Surgery Systems, United Kingdom, Revenue ($m) by Sub-Segment, Historic, 2003-2010 155
Figure 73: Beating Heart Surgery Systems, United Kingdom, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 157
Figure 74: Perfusion Disposables, United Kingdom, Revenue ($m) by Sub-Segment, Historic, 2003-2010 159
Figure 75: Perfusion Disposables, United Kingdom, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 161
Figure 76: Cardiovascular Surgery, United Kingdom, Volume (Units) by Segment, Historic, 2003-2010 163
Figure 77: Cardiovascular Surgery, United Kingdom, Volume (Units) by Segment, Forecast, 2010-2017 165
Figure 78: Beating Heart Surgery Systems, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2003-2010 167
Figure 79: Beating Heart Surgery Systems, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2010-2017 169
Figure 80: Perfusion Disposables, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2003-2010 171
Figure 81: Perfusion Disposables, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2010-2017 172
Figure 82: Cardiovascular Surgery, United Kingdom, Company Share (%), 2010 176
Figure 83: Electrophysiology, Market Segmentation 177
Figure 84: Electrophysiology Market, United Kingdom, Revenue Mix ($m), 2010 178
Figure 85: Electrophysiology Market, United Kingdom, Segment Contribution (%), 2010 179
Figure 86: Electrophysiology, United Kingdom, Revenue ($m) by Segment, Historic, 2003-2010 180
Figure 87: Electrophysiology, United Kingdom, Revenue ($m) by Segment, Forecast, 2010-2017 182
Figure 88: Electrophysiology, United Kingdom, Volume (Units) by Segment, Historic, 2003-2010 184
Figure 89: Electrophysiology, United Kingdom, Volume (Units) by Segment, Forecast, 2010-2017 186
Figure 90: Electrophysiology, United Kingdom, Company Share (%), 2010 190
Figure 91: External Defibrillators, Market Segmentation 192
Figure 92: External Defibrillators Market, United Kingdom, Revenue Mix ($m), 2010 193
Figure 93: External Defibrillators Market, United Kingdom, Segment Contribution (%), 2010 194
Figure 94: External Defibrillators, United Kingdom, Revenue ($m) by Segment, Historic, 2003-2010 195
Figure 95: External Defibrillators, United Kingdom, Revenue ($m) by Segment, Forecast, 2010-2017 197
Figure 96: External Defibrillators, United Kingdom, Volume (Units) by Segment, Historic, 2003-2010 199
Figure 97: External Defibrillators, United Kingdom, Volume (Units) by Segment, Forecast, 2010-2017 201
Figure 98: External Defibrillators, United Kingdom, Company Share (%), 2010 205
Figure 99: Interventional Cardiology, Market Segmentation 207
Figure 100: Interventional Cardiology Market, United Kingdom, Revenue Mix ($m), 2010 208
Figure 101: Interventional Cardiology Market, United Kingdom, Segment Contribution (%), 2010 209
Figure 102: Interventional Cardiology, United Kingdom, Revenue ($m) by Segment, Historic, 2003-2010 210
Figure 103: Interventional Cardiology, United Kingdom, Revenue ($m) by Segment, Forecast, 2010-2017 212
Figure 104: Cardiac Catheters, United Kingdom, Revenue ($m) by Sub-Segment, Historic, 2003-2010 214
Figure 105: Cardiac Catheters, United Kingdom, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 216
Figure 106: Coronary Stents, United Kingdom, Revenue ($m) by Sub-Segment, Historic, 2003-2010 218
Figure 107: Coronary Stents, United Kingdom, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 220
Figure 108: PTCA Balloons, United Kingdom, Revenue ($m) by Sub-Segment, Historic, 2003-2010 222
Figure 109: PTCA Balloons, United Kingdom, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 224
Figure 110: Intravascular Ultrasound Systems (IVUS), United Kingdom, Revenue ($m) by Sub-Segment, Historic, 2003-2010 226
Figure 111: Intravascular Ultrasound Systems (IVUS), United Kingdom, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 228
Figure 112: Interventional Cardiology, United Kingdom, Volume (Units) by Segment, Historic, 2003-2010 230
Figure 113: Interventional Cardiology, United Kingdom, Volume (Units) by Segment, Forecast, 2010-2017 232
Figure 114: Cardiac Catheters, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2003-2010 234
Figure 115: Cardiac Catheters, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2010-2017 235
Figure 116: Coronary Stents, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2003-2010 236
Figure 117: Coronary Stents, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2010-2017 237
Figure 118: PTCA Balloons, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2003-2010 238
Figure 119: PTCA Balloons, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2010-2017 240
Figure 120: Intravascular Ultrasound Systems (IVUS), United Kingdom, Volume (Units) by Sub-Segment, Historic, 2003-2010 242
Figure 121: Intravascular Ultrasound Systems (IVUS), United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2010-2017 244
Figure 122: Interventional Cardiology, United Kingdom, Company Share (%), 2010 249
Figure 123: Cardiac Catheters, United Kingdom, Company Share (%), 2010 251
Figure 124: Coronary Stents, United Kingdom, Company Share (%), 2010 253
Figure 125: Peripheral Vascular Devices, Market Segmentation 254
Figure 126: Peripheral Vascular Devices Market, United Kingdom, Revenue Mix ($m), 2010 255
Figure 127: Peripheral Vascular Devices Market, United Kingdom, Segment Contribution (%), 2010 256
Figure 128: Peripheral Vascular Devices, United Kingdom, Revenue ($m) by Segment, Historic, 2003-2010 258
Figure 129: Peripheral Vascular Devices, United Kingdom, Revenue ($m) by Segment, Forecast, 2010-2017 260
Figure 130: Stent Grafts, United Kingdom, Revenue ($m) by Sub-Segment, Historic, 2003-2010 262
Figure 131: Stent Grafts, United Kingdom, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 264
Figure 132: Inferior Vena Cava Filters (IVCF), United Kingdom, Revenue ($m) by Sub-Segment, Historic, 2003-2010 266
Figure 133: Inferior Vena Cava Filters (IVCF), United Kingdom, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 267
Figure 134: Peripheral Vascular Stents, United Kingdom, Revenue ($m) by Sub-Segment, Historic, 2003-2010 268
Figure 135: Peripheral Vascular Stents, United Kingdom, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 270
Figure 136: Peripheral Vascular Devices, United Kingdom, Volume (Units) by Segment, Historic, 2003-2010 272
Figure 137: Peripheral Vascular Devices, United Kingdom, Volume (Units) by Segment, Forecast, 2010-2017 274
Figure 138: Stent Grafts, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2003-2010 276
Figure 139: Stent Grafts, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2010-2017 278
Figure 140: Inferior Vena Cava Filters (IVCF), United Kingdom, Volume (Units) by Sub-Segment, Historic, 2003-2010 279
Figure 141: Inferior Vena Cava Filters (IVCF), United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2010-2017 281
Figure 142: Peripheral Vascular Stents, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2003-2010 283
Figure 143: Peripheral Vascular Stents, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2010-2017 285
Figure 144: Peripheral Vascular Devices, United Kingdom, Company Share (%), 2010 290
Figure 145: Prosthetic Heart Valves, Market Segmentation 292
Figure 146: Prosthetic Heart Valves Market, United Kingdom, Revenue Mix ($m), 2010 293
Figure 147: Prosthetic Heart Valves Market, United Kingdom, Segment Contribution (%), 2010 294
Figure 148: Prosthetic Heart Valves, United Kingdom, Revenue ($m) by Segment, Historic, 2003-2010 295
Figure 149: Prosthetic Heart Valves, United Kingdom, Revenue ($m) by Segment, Forecast, 2010-2017 297
Figure 150: Mechanical Heart Valves, United Kingdom, Revenue ($m) by Sub-Segment, Historic, 2003-2010 299
Figure 151: Mechanical Heart Valves, United Kingdom, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 301
Figure 152: Tissue Heart Valves, United Kingdom, Revenue ($m) by Sub-Segment, Historic, 2003-2010 303
Figure 153: Tissue Heart Valves, United Kingdom, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 305
Figure 154: Prosthetic Heart Valves, United Kingdom, Volume (Units) by Segment, Historic, 2003-2010 307
Figure 155: Prosthetic Heart Valves, United Kingdom, Volume (Units) by Segment, Forecast, 2010-2017 309
Figure 156: Mechanical Heart Valves, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2003-2010 311
Figure 157: Mechanical Heart Valves, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2010-2017 313
Figure 158: Tissue Heart Valves, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2003-2010 315
Figure 159: Tissue Heart Valves, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2010-2017 317
Figure 160: Prosthetic Heart Valves, United Kingdom, Company Share (%), 2010 321
Figure 161: Medtronic, Inc., Company Share (%),United Kingdom Cardiovascular Devices Market, 2010 322
Figure 162: Boston Scientific Corporation, Company Share (%),United Kingdom Cardiovascular Devices Market, 2010 323
Figure 163: St. Jude Medical, Inc., Company Share (%),United Kingdom Cardiovascular Devices Market, 2010 324
Figure 164: Abbott Laboratories, Company Share (%),United Kingdom Cardiovascular Devices Market, 2010 325
Figure 165: Cordis Corporation, Company Share (%),United Kingdom Cardiovascular Devices Market, 2010 326
Figure 166: Sorin S.p.A., Company Share (%),United Kingdom Cardiovascular Devices Market, 2010 327

Upcoming Reports:

Hydrogen Generation (Merchant And On-Site) Market - Global Industry Analysis, Size, Share, Growth And Forecast, 2012 - 2018
By - Transparency Market Research
Hydrogen gas is a major energy source and is widely used in various industrial sectors such as petroleum refineries, chemical processing, automotive fuel, fuel cells, aerospace and many more. Commercially, hydrogen gas is produced by steam reformation of natural gas or by partial oxidation of petroleum oil.  Hydrogen gas can be segmented into captive hydrogen generation and merchant hydrogen generation. The former involves the production of hydrogen by a company for self consumption in its business operations, whereas the latter involves purchase of hydrogen gas as a...
Natural Colorants Market - Global Industry Trends, Market Share, Analysis And Forecast, 2012 - 2018
By - Transparency Market Research
Natural colors are types of food additives which are extracted from natural sources and added in food to improve its taste and appearance. Colorants are used to enhance the color of a product, to restore the color lost during processes, to standardize the color and its appearance and to increase acceptability of food. Food is the largest application segment for natural colorants with over 32% market share, followed by soft drinks and alcoholic beverages. The colors market is estimated at $1.8 billion in 2010, and natural colors market is estimated at $.66 billion of...
Mobile Commerce Market - Global Industry Size, Market Share, Trends, Analysis, And Forecast, 2012 - 2017
By - Transparency Market Research
Mobile commerce is handled by devices like laptops, cellular phones, Smart phones and tablet computers to execute online commercial transactions. Mobile commerce is experiencing continuous growth in a variety of fields including sales and purchase of a wide range of services and goods, payments of bills, net banking and so on. All these transactions are collectively known as m-commerce or mobile commerce. Mobile commerce is a successor of e-commerce but with its unique functionalities it should be viewed as the next powerful tool to communicate with the customers....

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.com
Select License type:

Share this report

Related News

One-third of Massachusetts Hospitals Facing Financial Downturn
Sep 14, 2012  
The healthcare Industry in the United States works as a separate entity and many of the healthcare services are privately owned and operated. Healthcare has always been a topic of debate for the U.S. government because policy makers argue that the system is not delivering value for money services. In fact government is spending twice as much on life expectancy and infant mortality rate...
Now At-Home TB Diagnosis Looks Possible
Sep 14, 2012  
According to a recent research published in Nature Chemistry, scientists have revealed that a certain sensitive fluorescent molecule is capable of efficiently and quickly tracing TB (tuberculosis) bacteria from the sputum samples. The year 2010 registered approximately 4000 deaths per day because of TB. TB diagnosis takes a few weeks and the disease being contagious puts others at...
China Economy Gets USD 157 Billion Stimulus with Sanction for 60 Infrastructure Projects
Sep 14, 2012  
Seen as a much required economical stimulus to revive the economy stuck in the worst slowdown in the past three years, China has approved 60 different infrastructure projects valued at more than USD 150 billion. Immediately after the official confirmation of the decision, stocks of major industries such as cement and steel have seen a rise on hopes generated by plans to build ports, highways,...
Battling against flu, vaccination necessary for health workers
Sep 14, 2012  
To battle against flu this season, health officials have tightened their resolve to get more health care workers vaccinated. Flu is a disease that transfers from one to another. Keeping this in mind health officials want every worker in the health care department to get vaccinated. By doing this, it will lessen the chances of others getting affected by this disease. Health officials...
Japan to Cut Import Duties on Indian Generic Drugs Imports
Sep 14, 2012  
The 44th ASEAN Economic Ministers Meeting held last week in Cambodia has certainly brought good news for the Indian Pharmaceuticals industry. During the meeting on the sidelines of the 44th ASEAN Economic Ministers Meet, Indian Commerce and Industry Minister Anand Sharma brought up the issue with his Japanese counterpart Yukio Edano. Yukio Edano is the minister of economy, trade and Industry...